S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,108.07 +0.33%
Next Bullish Trade
Sign in
BRKRP

Bruker Corporation NMS · BRKRP

$434.02 -5.09 (-1.16%)
Neutral · +0.08σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · BRKRP

Momentum reads · latest daily bar
Last
$434.02
-5.09 (-1.16%)
RSI(14)
52.6
neutral
Stochastic %K
36.3
neutral
MFI(14)
38.4
neutral
ADX(14)
18.3
weak trend

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $0.8B $0.0B $0.0B $0.0B 1.7% 4.4%
2025-12-31 $1.0B $0.0B $0.1B $0.2B 2.7% 11.4%
2025-09-30 $0.9B $-0.1B $0.0B $-0.1B -6.9% 4.1%
2025-06-30 $0.8B $0.0B $0.0B $-0.1B 1.0% 3.3%
2025-03-31 $0.8B $0.0B $0.1B $0.0B 2.2% 8.6%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare BRKRP vs peers

Line BRKRP up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing BRKRP NVDA×
Verdict
Weighted score 0-100 across 2 tickers · best in green
#2
BRKRP
score 23.5
4/5 inputs
Momentum scores perfect 100 with 41.81% three-month gain, but zero scores in value, growth, and quality drag overall rank.
value 0growth 0quality 0momentum 100
#1
NVDA
score 62.1
5/5 inputs
Growth dominates with 85.2% revenue expansion and 214.5% EPS growth, earning perfect 100 growth and quality scores despite weak momentum.
value 58growth 100quality 100momentum 0sentiment 50
BRKRP
Bruker Corporation
$434.02
-1.16%
Snapshot
Price 434.02
Day % -1.16
1M % 4.21
3M % 41.81
YTD % 17.45
Market cap
ADV ($) 9541061.418487549
Beta 1.293
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 0.23
Dist ATR (σ) 0.08
OdysseyHQ grade
Confluence 2
Valuation
P/E (ttm)
P/E (fwd)
P/S
EV/EBITDA 138.519
P/B 26.976192
FCF yield
PEG
Growth
Revenue yoy 0.027
EPS yoy -0.818
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.47616002
Operating margin 0.06182
Net margin -0.0033500001
ROE -0.0043200003
ROA 0.026989998
Debt / Equity 0.68
Interest cov. 1.36
Technicals
RSI(14) 52.6
MACD signal neutral
vs 50-DMA 7.22
vs 200-DMA 25.79
vs 52w high -6.38
HV-30 46.4
Sentiment
Analyst rec
Target upside
Insider buy-sell 90d
Risk
Short interest
Days to cover 0.13
Next earnings
Full BRKRP dashboard →
NVDA
NVIDIA Corporation
$202.81
-2.21%
Snapshot
Price 202.81
Day % -2.21
1M % -2.22
3M % 2.25
YTD % 7.39
Market cap 4912260841472.0
ADV ($) 31778772484.42035
Beta 2.211
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % -0.9
Dist ATR (σ) -0.25
OdysseyHQ grade
Confluence 2
Valuation
P/E (ttm) 31.058191
P/E (fwd) 15.80593
P/S 19.378443
EV/EBITDA 29.409
P/B 25.131351
FCF yield 0.0094
PEG 0.56
Growth
Revenue yoy 0.852
EPS yoy 2.145
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.74144995
Operating margin 0.65596
Net margin 0.62966
ROE 1.14288
ROA 0.52727
Debt / Equity 0.07
Interest cov. 547.14
Technicals
RSI(14) 48.2
MACD signal bull
vs 50-DMA -3.38
vs 200-DMA 5.41
vs 52w high -14.26
HV-30 41.6
Sentiment
Analyst rec 1.29508
Target upside 49.06
Insider buy-sell 90d -5
Risk
Short interest 1.3300001000000001
Days to cover 1.9
Next earnings 2026-08-26
Full NVDA dashboard →

Earnings replay · last 0 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

No earnings history available.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
BRKRP 138.5 27.0 47.6% 2.7% -81.8%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0%
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 76.89%

HolderShares% out
Aequim Alternative Investments LP 500,000 18.12%
FMR, LLC 446,800 16.19%
Shaw D.E. & Co., Inc. 205,000 7.43%
Franklin Resources, Inc. 200,000 7.25%
Blackrock Inc. 190,827 6.91%
TPG GP A, LLC 163,000 5.91%
Calamos Advisors LLC 141,961 5.14%
Wolverine Asset Management, LLC 127,791 4.63%
Van Eck Associates Corporation 74,383 2.70%
Ameriprise Financial, Inc. 72,000 2.61%

Insider activity · 90d

No insider trades for BRKRP in last 90d.

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$—
Mean
$—
High
$—
Analysts
Recommendation distribution · period 2026-07-01
6
8
6
1
Revision trend (2026-04-01 → 2026-07-01): net 14 → 13 -1 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-16 Insider transaction (Form 4) view ·
4 2026-06-16 Insider transaction (Form 4) view ·
8-K 2026-05-21 8-K view ·
4 2026-05-19 Insider transaction (Form 4) view ·
4 2026-05-18 Insider transaction (Form 4) view ·
8-K 2026-05-15 8-K view ·
10-Q 2026-05-07 10-Q view ·
8-K 2026-05-06 8-K view ·
8-K 2026-04-28 8-K view ·
4 2026-04-16 Insider transaction (Form 4) view ·
DEF 14A 2026-04-10 DEF 14A view ·
8-K 2026-04-10 8-K view ·
8-K 2026-04-01 8-K view ·
4 2026-03-16 Insider transaction (Form 4) view ·
10-K 2026-02-27 10-K view ·
8-K 2026-02-20 8-K view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
8-K 2026-02-12 8-K view ·
4 2026-01-16 Insider transaction (Form 4) view ·
4 2026-01-13 Insider transaction (Form 4) view ·
8-K 2026-01-12 8-K view ·
4 2026-01-06 Insider transaction (Form 4) view ·
8-K 2025-12-09 8-K view ·
4 2025-12-02 Insider transaction (Form 4) view ·
4 2025-11-10 Insider transaction (Form 4) view ·
10-Q 2025-11-05 10-Q view ·
8-K 2025-11-03 8-K view ·
4 2025-09-12 Insider transaction (Form 4) view ·
8-K 2025-09-08 8-K view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-12 Insider transaction (Form 4) view ·
4 2025-08-12 Insider transaction (Form 4) view ·
4 2025-08-12 Insider transaction (Form 4) view ·
4 2025-08-07 Insider transaction (Form 4) view ·
4 2025-08-07 Insider transaction (Form 4) view ·
4 2025-08-07 Insider transaction (Form 4) view ·
10-Q 2025-08-06 10-Q view ·
8-K 2025-08-04 8-K view ·
8-K 2025-07-21 8-K view ·
4 2025-06-09 Insider transaction (Form 4) view ·
8-K 2025-05-29 8-K view ·
4 2025-05-19 Insider transaction (Form 4) view ·
4 2025-05-14 Insider transaction (Form 4) view ·
8-K 2025-05-14 8-K view ·
10-Q 2025-05-07 10-Q view ·

About BRKRP

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic for…

Options picks · BRKRP

ITM + OTM ideas from the latest scan

Loading…

Congress trades · BRKRP

STOCK Act disclosures

Loading…

SEC filings & insiders · BRKRP

EDGAR · live

Loading…

Holders · BRKRP

Institutions & insider activity

Loading…